Pomegra
Sequoia leads a $1 billion Series B in microreactor startup Valar Atomics, valuing the company at $6 billion amid surging AI data center power demand.
- Valar Atomics closed a $1B equity round led by Sequoia, plus a $200M credit line from Erebor and partner banks, at a $6B post-money valuation.
- The startup's NOVA and Ward 250 reactors both achieved zero-power criticality in 2025, making Valar the first venture-backed firm to do so.
- Founder Isaiah Taylor is pivoting from reactor demonstration to volume manufacturing, with AI data centers as the primary customer target.
Lead
Valar Atomics, the Utah-based nuclear microreactor startup founded by Isaiah Taylor, closed a $1 billion Series B on August 3, 2026, led by Sequoia Capital, with Sequoia partner Shaun Maguire joining the board. A concurrent $200 million credit line from Erebor and other banks brings total fresh capital to $1.2 billion. The round values the company at $6 billion - a figure that establishes Valar as one of the most heavily capitalized nuclear startups in history, just months after it demonstrated that a venture-backed organization could sustain a nuclear chain reaction.
What Does Valar Atomics Actually Build?
The company's core product is a helium-cooled, TRISO-fueled high-temperature gas microreactor. Its Ward 250 unit sits at the San Rafael Energy Research Center in Emery County, Utah, a state-owned facility that gave Valar access to test infrastructure most private nuclear developers spend years trying to secure. Each unit is compact enough, Taylor has argued, to power roughly 5,000 homes continuously - the kind of uninterrupted baseload that variable renewables can't provide and that AI inference clusters specifically require.
Taylor himself is an unusual figure in deep tech: a high-school dropout with a background in auto repair and software who built the company's early engineering culture around speed and regulatory pragmatism. He has framed nuclear permitting in the West as the central bottleneck and positioned Valar's reactor design around regulatory pathways that avoid the most congested approval queues.
Why Is Sequoia Writing a Billion-Dollar Check for Nuclear?
The straightforward answer is power. Hyperscalers and their data center suppliers have been public for two years about their inability to find grid capacity fast enough to match GPU deployment timelines. Microreactors, which can be sited off-grid or adjacent to existing industrial infrastructure, address exactly that constraint.
Sequoia's bet is not simply on nuclear as a category. It is on Valar's demonstrated technical progress. In November 2025, the company's NOVA reactor reached zero-power criticality - producing 10 critical configurations across 100 gigabytes of experimental data in a week-long campaign. Ward 250 followed. No other venture-backed nuclear firm had achieved criticality before Valar. That milestone mattered to investors who had watched prior nuclear startups spend hundreds of millions without ever touching fission.
Other participants in the Series B include Point72, Conviction, Riot Ventures, HOF Capital, Dream Ventures, Snowpoint Ventures, Atreides Management, Apandion Capital, and Valor Equity Partners. The round also follows a $130 million tranche disclosed earlier in 2026 that included Palmer Luckey and Palantir CTO Shyam Sankar, signaling that defense-adjacent capital had already identified Valar's remote-base power potential before Sequoia moved.
From Demonstration to Production
Taylor's stated intent for the proceeds is a shift from proving the technology to manufacturing it at scale. That transition is where nuclear startups have historically stalled: criticality in a test environment does not translate automatically to deployable units, and the supply chains for specialized nuclear components are narrow. Valar will need to navigate Nuclear Regulatory Commission licensing for any commercial deployment in the U.S., a process that has taken competitors years even with favorable regulatory posture under recent administrations.
The $6 billion valuation also implicitly reprices the earlier $130 million round, compressing the markup timeline in ways that will draw scrutiny if production timelines slip.
Outlook
Valar enters its production phase with more capital than most nuclear startups see across their entire lifetimes and with two criticality milestones on the books. The core risk is execution speed: the gap between a functional test reactor and a certified, deployable commercial unit is where the money tends to disappear. Sequoia's involvement raises the profile and the expectations simultaneously. If Taylor can deliver a manufacturable design inside the current regulatory window, the $6 billion figure will look conservative. If the NRC licensing process runs long, the burn rate against that timeline will become the story.
